|
Pharmaceuticals Industry
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence. Included here are companies engaged not only in pharmaceutical development, but also supply chain management and device development, including compounding pharmacies. Retail pharmacies; firms specialized in the collection, fractionation and distribution of human blood; and medical device manufacturers where the device is not related to pharmaceutical administration are not included. Entry titles have been shortened in a number of cases, so that if the article title of a company is "XYZ Pharma", for instance, the entry will appear here as "XYZ". Companies which existed as a joint venture for their entire existence are indicated by a super-script "JV", as in PerseidJV. Alphabetical listing—Active firms ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Pharmaceutical Companies
The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients (or self-administered), with the aim to cure them, vaccinate them, or alleviate symptoms. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy using drug testing and marketing of drugs. The global pharmaceuticals market produced treatments worth $1,228.45 billion in 2020 and showed a compound annual growth rate (CAGR) of 1.8%. History Mid-1800s – 1945: From botanicals to the first synthetic drugs The modern era of pharmaceutical industry began with local apothecaries that expanded from their traditional role of distributing botanical drugs such as morphine and quinine to wholesale manufacture in the mid-1800s, and from discoveries resulting from applied research. Intentional drug d ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Alkermes (company)
Alkermes plc is a pharmaceutical company that focuses on central nervous system (CNS) diseases like schizophrenia, bipolar disorder, depression, addiction and multiple sclerosis. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and manufacturing facilities in Athlone, Ireland, and Wilmington, Ohio. Products Alkermes has more than 20 commercial drug products and candidates that address serious and chronic illnesses, including schizophrenia, depression, addiction, and diabetes mellitus. Among these products, five are primary to the company: risperidone (microspheres) long-acting injectable (''Risperdal Consta'') for schizophrenia and bipolar 1 disorder, paliperidone palmitate (''Invega Sustenna'' in the U.S., ''Xeplion'' in Europe) for sc ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Assertio Therapeutics
Assertio Therapeutics, Inc. (formerly Depomed, Inc.) is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. History 1995-2009 Depomed was founded in 1995 and later became headquartered in Newark, California. A joint venture between Élan and Depomed, DDL, was established in January 2000. Élan withdrew from operational involvement in September 2003, with Depomed gaining full ownership. In September 2003, the company's subsidiary Depomed Development Ltd. acquired the exclusive righ ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Aspen Pharmacare
Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange (JSE) in 1998 and purchased South African Druggists in 1999 before expanding into international markets. Currently the largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany,https://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/5314756/GSK-expands-into-emerging-markets-with-Aspen-deal.html Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals (ARVs)https://www.bizcommunity.com/Article/196/162/25995.html and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine thr ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
AryoGen
AryoGen Pharmed ( fa, آریوژن فارمد) is an Iranian biopharmaceutical company specializing in manufacturing Therapeutic Monoclonal antibodies and some other recombinant proteins. History AryoGen is a biopharmaceutical company created on the mandate of Iranian executive branch. It was created by a group of scientific experts spun off a Biopharmaceutical company, which formed a new entity named AryoGen Pharmed which started its production in 2011. It was deemed an issue of national interest due to the importance of the target products on Iran's community health care system, as well as its impact in the region and globally. AryoGen is the world's first company to produce biosimilar Blood Coagulation Factor VII, which required a 50 million Euro investment. Also AryoGen has established a monoclonal antibody production line, making it one of only 10 manufacturers in the world. AryoGen changed its name to AryoGen Pharmed in 2016. AryoGen Pharmed (AryoGen) has received a Good ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly traded Canadian (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Vancouver, British Columbia and has research facilities in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. History Tekmira, as the company was formerly called, was formed as a wholly owned subsidiary of Inex Pharmaceuticals in 2005 after that company began collapsing after its regulatory and partnering strategy failed in 2004. Tekmira was fully spun out in 2007 and Tekmira absorbed the assets of Inex, which had been founded in 1992. Inex had been developing liposomal formulations of off-patent cancer drugs, and licensed them to Talon Pharmaceuticals in 2005; Talon was acquired by Spectrum Pharmaceuticals in 2013, and three former Inex/Tekmira products reached the mar ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Apotex
Apotex Inc. is a Canadian pharmaceutical corporation. Founded in 1974 by Barry Sherman, the company is the largest producer of generic drugs in Canada, with annual sales exceeding . By 2016, Apotex employed over 10,000 people as one of Canada's largest drug manufacturers, with over 300 products selling in over 115 countries. Revenues were about CA$1.19 billion annually. Apotex manufactures and distributes generic medications for a range of diseases and health conditions that include cancer, diabetes, high cholesterol, glaucoma, infections and blood pressure. Apotex is a member of the Canadian Generic Pharmaceutical Association (CGPA), the Generic Pharmaceutical Association (GPhA), an associate member of the Canadian Animal Health Institute (CAHI), the Canadian Association for Pharmacy Distribution Management (CAPDM), as well as the Greater Toronto Area's Partners in Project Green. History Apotex began with limited staff in a 5,000-square-foot warehouse. When Barry Sherman started ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Antibody Solutions
Antibody Solutions is a privately held American contract research organization headquartered in Santa Clara, California. It provides research and discovery services and fit-for-purpose antibodies to biopharmaceutical and diagnostic companies and academic researchers worldwide. The company’s services include monoclonal and polyclonal antibody and antigen development, molecular modeling, antibody sequencing and engineering, bioreactor technology, pharmacokinetic studies, antibody epitope binning, peptide synthesis, immunoassay development, ligand-binding assay analysis, and support for CAR-T research. History Antibody Solutions was founded in 1995 by current president, John Kenney, PhD, Judith Lynch-Kenney, and Dennis and Bette Gould. Dr. Kenney previously managed the monoclonal antibody (MAb) development laboratory for Syntex Research (Roche) in Palo Alto, while Gould managed the MAb production facility for Syva Diagnostics. Gould left Antibody Solutions in 1997, eventually beco ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey. History Amneal Pharmaceuticals was founded in 2002 by brothers Chirag and Chintu Patel. The company manufactured its first prescription product in 2005 and received its first in 2006. In 2007, the company acquired five divested drugs from Mylan which Mylan was forced to sell as part of their acquisition of the generics unit of Merck KGaA. At this time, the company was noted as being a private company based in Paterson, New Jersey. After the 2007 acquisition of Akyma Pharmaceuticals, a Glasgow, Kentucky-based regional distributor, Amneal launched its own product label. In 2008, the company expanded into India with the development of an R&D Centre in Gujarat. Continued expansion in the United States occurred between 2010 and 2016 in New Jersey, New York and Kentucky. As of 2017, the company had grown much of i ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Amgen
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical Corporation, company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.Baker, Pam (2002). ''Thousand Oaks Westlake Village: A Contemporary Portrait''. Community Communications, Inc. Page 37. . Amgen's Thousand Oaks staff in 2017 numbered 5,125 (7.5% of total city employment) and included hundreds of scientists, making Amgen the largest employer in Ventura County, California, Ventura County. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Alzheon
Alzheon is an American clinical-stage biopharmaceutical company based in Framingham, Massachusetts. The company is developing medicines for patients with Alzheimer's disease and other neurological and psychiatric disorders A mental disorder, also referred to as a mental illness or psychiatric disorder, is a behavioral or mental pattern that causes significant distress or impairment of personal functioning. Such features may be persistent, relapsing and remitti .... History Alzheon was founded in July 2013 by Martin Tolar, MD, PhD, a veteran of Alzheimer's drug programs, who serves as president and CEO of the organization. Alzheon completed a $10 million Series A round of financing in April 2015 and started the Phase lb bridging clinical program for ALZ-801, which was completed in July 2016. In August 2018, Alzheon appointed former IVAX President Neil Flanzraich, JD, as Vice Chairman of Board of Directors. In August 2020, Alzheon was awarded a $47 million grant over five ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Altana
Altana AG (styled as ALTANA) is a German chemical company headquartered in Wesel. It was created in 1977 through the spin-off of divisions of the Varta Group. The first CEO was Herbert Quandt. The group comprises the divisions BYK (coating additives and instruments), Eckart (metal effect pigments and metallic printing inks), Elantas (insulation materials for the electrical and electronics industries) and Actega (coatings and sealant compounds for the packaging industry). The Altana Group has 48 production facilities and 65 service and research laboratories worldwide. In 2021, the company, with more than 6,700 employees, posted revenues of around €2.7 billion. History Altana's roots go back to 1873, when Heinrich Byk founded the chemicals factory Dr. Heinrich Byk Chemische Fabrik in Oranienburg. The company grew, and in 1931 it was renamed BYK-Gulden Lomberg. In 1941, majority control of the company was acquired by AFA (Akkumulatoren-Fabrik AG) which was renamed VARTA in ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
_(6982162417).jpg "Click for more on -> Pharmaceutical Companies")
